Insider Stock Trading History of Nudelman Phillip M Phd


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nudelman Phillip M Phd since year 2005. The trader's CIK number is 1041084. At the time of this reporting, Nudelman Phillip M Phd is the Director of Cell Therapeutics Inc . (stock ticker symbol CTIC). See this page for all insider trading activities at Cell Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Nudelman Phillip M Phd since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-04-29 CTIC Cell Therapeutics Inc Option Ex 39,698 .00 0
2015-09-29 CTIC Cell Therapeutics Inc Sale 14,380 1.45 20,865
2015-09-30 CTIC Cell Therapeutics Inc Sale 135,620 1.45 196,649
2014-03-25 CTIC Cell Therapeutics Inc Sale 100,000 3.56 356,100
2013-08-06 CTIC Cell Therapeutics Inc Sale 50,000 1.09 54,550
2013-03-08 CTIC Cell Therapeutics Inc Sale 103,900 1.29 134,031
2013-03-07 CTIC Cell Therapeutics Inc Sale 46,100 1.31 60,298
2012-06-29 CTIC Cell Therapeutics Inc Sale 200,000 .58 115,999
2011-02-28 CTIC Cell Therapeutics Inc Sale 40,000 .29 11,640
2011-01-31 CTIC Cell Therapeutics Inc Sale 40,000 .35 14,160
2010-12-31 CTIC Cell Therapeutics Inc Sale 40,000 .37 14,680
2010-11-30 CTIC Cell Therapeutics Inc Sale 40,000 .35 14,120
2010-10-29 CTIC Cell Therapeutics Inc Sale 40,000 .38 15,120
2010-09-30 CTIC Cell Therapeutics Inc Sale 40,000 .38 15,320
2010-08-31 CTIC Cell Therapeutics Inc Sale 40,000 .36 14,520
2010-07-30 CTIC Cell Therapeutics Inc Sale 40,000 .40 15,800
2010-06-30 CTIC Cell Therapeutics Inc Sale 40,000 .39 15,480
2010-05-28 CTIC Cell Therapeutics Inc Sale 40,000 .39 15,560
2010-05-03 CTIC Cell Therapeutics Inc Sale 40,000 .60 23,960
2009-08-14 CTIC Cell Therapeutics Inc Sale 164,000 1.57 257,480
2008-03-18 CTIC Cell Therapeutics Inc Buy 25,000 .57 14,249

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nudelman Phillip M Phd (Director of Cell Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.